Presenilin-dependent gamma-secretase activity modulates thymocyte development.
about
Presenilin-1 interacts with plakoglobin and enhances plakoglobin-Tcf-4 association. Implications for the regulation of beta-catenin/Tcf-4-dependent transcriptionPapillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activationNotch signaling in CD4 and CD8 T cell developmentIn vivo notch signaling blockade induces abnormal spermatogenesis in the mouseBACE1 and presenilin: two unusual aspartyl proteases involved in Alzheimer's diseasePresenilins regulate alphabeta T cell development by modulating TCR signalingGamma-secretase-dependent and -independent effects of presenilin1 on beta-catenin.Tcf-4 transcriptional activityGenomic deletion of GIT2 induces a premature age-related thymic dysfunction and systemic immune system disruption.A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafishComplementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation.E proteins and the regulation of early lymphocyte developmentThe γ-secretase complex: from structure to function.The role of Notch signaling during hematopoietic lineage commitment.Alzheimer's disease: beta-Amyloid protein and tau.A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.Amyloid, presenilins, and Alzheimer's disease.Aspartic proteases involved in Alzheimer's disease.An overview of notch signaling in adult tissue renewal and maintenance.Notch regulates cytolytic effector function in CD8+ T cells.Wheat germ agglutinin enhanced cerebral uptake of anti-Aβ antibody after intranasal administration in 5XFAD micePresenilins and γ-secretase: structure, function, and role in Alzheimer Disease.Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease.TCR and Notch signaling in CD4 and CD8 T-cell development.Effect of presenilins in the apoptosis of thymocytes and homeostasis of CD8+ T cellsNotch signaling in T-cell acute lymphoblastic leukemia.Gamma-secretase activation of notch signaling regulates the balance of proximal and distal fates in progenitor cells of the developing lung.Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells.Amyloid precursor family proteins are expressed by thymic and lymph node stromal cells but are not required for lymphocyte development.Presenilins, Notch dose control the fate of pancreatic endocrine progenitors during a narrow developmental window.Distinct transcriptional programs in thymocytes responding to T cell receptor, Notch, and positive selection signals.Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors.Enforcement of γδ-lineage commitment by the pre-T-cell receptor in precursors with weak γδ-TCR signals.A survey of peptides with effective therapeutic potential in Alzheimer's disease rodent models or in human clinical studies.Intramembrane proteolysis of GXGD-type aspartyl proteases is slowed by a familial Alzheimer disease-like mutation.A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes.Functional overexpression of gamma-secretase reveals protease-independent trafficking functions and a critical role of lipids for protease activity.Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation.BACE1- and BACE2-expressing human cells: characterization of beta-amyloid precursor protein-derived catabolites, design of a novel fluorimetric assay, and identification of new in vitro inhibitors.Identification of a beta-secretase activity, which truncates amyloid beta-peptide after its presenilin-dependent generation.Characterization of alpha 2,6-sialyltransferase cleavage by Alzheimer's beta -secretase (BACE1).
P2860
Q24296830-28979685-3C96-41E2-8A0A-E2FC1C349F75Q24563952-1A2A2D33-7B60-4D58-AD11-08EF1F40C630Q24656638-89DC6B34-A62F-4959-A573-723D5331D13FQ27324283-F63BD021-AA25-4E53-A997-F31BA91230EAQ28257726-76746367-6E5C-42C2-BB95-CAC574CA31D6Q28587555-9D2D655D-51D8-45AB-B8E5-5BBE927B0BB3Q30856526-5F278BBC-475E-41B5-A8DD-CFAD815B9DAEQ33563570-5BD90465-5059-4487-AE9A-255D7D701E12Q33758025-D35DC19D-FC2B-428B-81CF-B0AB7A88796EQ33843034-417F92FA-2103-4D0E-A21D-48FE107D1B70Q34356462-EDACCD7F-3C4C-499E-AC95-5D41ABC01AC0Q34677532-B2DD11D9-C4DE-46F6-A379-4D590AFEF40AQ34941712-0442CB5A-39EC-4D6B-A124-F4E5E99F634FQ34976291-7263632F-18F6-464D-A0C5-57F512F82E89Q35103136-C382FB08-3CE4-4618-B1C8-FF3555255D5CQ35112198-C1882645-E22E-44A0-9B29-2A5C903D6052Q35125093-BBB5A9C3-FF46-493B-8574-948C8856B48FQ35180702-488A70B0-0312-407F-ABF6-C997247318F4Q35219642-E8037FFD-F4DE-4309-8E90-4ABD0FB0A237Q35300928-774813DF-5916-4183-8B2F-6EC483EE6F55Q35658184-4AE35444-8EE2-4C08-A742-B82B8ABE6BB9Q36300032-3D202105-2331-4C4F-9E19-BBDDE35C6362Q36382785-BD5595D1-01DA-489E-B415-EEB25D24D0A5Q36384841-B966A11B-2580-43BC-A96F-3D49B429FAA7Q36429535-CCD5F0C4-CA5B-496F-BB55-F02F28D17284Q36944852-745F6256-0E52-4ACA-93AA-BAA013C45665Q37061440-A464DD4A-A2E4-4A30-BF5F-81FE13207170Q37360497-E0F45EC1-8FCA-4BEF-8196-A512ED2DB5EAQ37362813-FCF9AAE8-5BCD-4EAA-B9E5-939B75D90950Q37415532-567A8056-EE2D-4F3F-9730-3E858EA7C2E8Q37419676-788B90BE-5F27-41E0-9860-6377F10A58DCQ37711954-D168710C-60B8-46C7-9433-FB10C2E16B53Q37981246-DCAAF517-5CCA-4B84-B262-DDDD5DA828ADQ39944020-8711B351-5EAE-46CE-88F6-080BD0662F8DQ40262258-01F7DBAD-3660-4BAC-84F5-F71F87E88A7EQ40478080-218DB02A-62EA-4C39-B46E-F96683493ED0Q40601680-9E8E067C-48D1-4A8D-B2FE-DEBFE0484D99Q40649318-BDD2B3DC-E766-4853-97CE-80DAE645ED36Q40684851-1E579B49-2861-445E-8E3D-CB85F050E214Q44243372-3179E0BC-21B8-440D-84FB-E1980CEFFE2A
P2860
Presenilin-dependent gamma-secretase activity modulates thymocyte development.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Presenilin-dependent gamma-secretase activity modulates thymocyte development.
@ast
Presenilin-dependent gamma-secretase activity modulates thymocyte development.
@en
type
label
Presenilin-dependent gamma-secretase activity modulates thymocyte development.
@ast
Presenilin-dependent gamma-secretase activity modulates thymocyte development.
@en
prefLabel
Presenilin-dependent gamma-secretase activity modulates thymocyte development.
@ast
Presenilin-dependent gamma-secretase activity modulates thymocyte development.
@en
P2093
P2860
P356
P1476
Presenilin-dependent gamma-secretase activity modulates thymocyte development.
@en
P2093
Doerfler P
Perlmutter RM
Shearman MS
P2860
P304
P356
10.1073/PNAS.161102498
P407
P577
2001-07-24T00:00:00Z